Skip to content
Dx

ICD-10-PCS 2027 procedure code

XW013V7Introduction of COVID-19 Vaccine Dose 3 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7

✓ Valid for 2027

Short description: Introduce COVID19 Vacc Ds 3 in Subcu, Perc, New Tech 7

Code last changed in FY2022 (effective October 1, 2021). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data

About XW013V7

XW013V7 is the ICD-10-PCS code for a introduction procedure on the subcutaneous tissue using a percutaneous approach with COVID-19 vaccine dose 3 (qualifier: new technology group 7). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

For a different body part, codes include XW023V7 (muscle).

With a different device, use XW013W7 (AGN1 bone void filler).

It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.

It was added in FY2022, effective October 1, 2021.

What each character means

1. Section
XNew Technology
2. Body System
WAnatomical Regions
3. Operation
0Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4. Body Part
1Subcutaneous Tissue
5. Approach
3Percutaneous

Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure

6. Device / Substance / Technology
VCOVID-19 Vaccine Dose 3
7. Qualifier
7New Technology Group 7

Other versions of this procedure

Different body part

Different device / substance / technology

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2022 (effective 10/1/2021): Added
  • No changes since FY2022.

Common questions about XW013V7

Is XW013V7 a valid ICD-10-PCS code for 2027?

Yes. XW013V7 is valid for inpatient procedures from October 1, 2026 through September 30, 2027.